Discover 861 paid clinical trials in Daytona Beach, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 861
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Orange City FL, Bay Pines FL, Boca Raton FL,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06899126
Phase3, Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for
Lymphoma, Large B-Cell, Diffuse
Location: Orange City FL, Jacksonville FL, Boca Raton FL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06890884
Phase2, Recruiting
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
for
Non-small Cell Lung Cancer
Location: Orange City FL, Atlanta GA, Marietta GA, Fairfax VA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07195695
Phase3, Recruiting
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
for
Advanced/Metastatic Non-Small Cell Lung Cancer,
Location: Orange City FL, Orlando FL, Coral Springs FL,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07227298
Phase1, Phase2, Recruiting
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Location: Orange City FL, Bethesda MD, Toledo OH, Houston TX,
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Sex: All
Age: 18+
Code: NCT06095583
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
for
Diffuse Large B-Cell Lymphoma
Location: Orange City FL, Ocoee FL, Clermont FL, Bethesda MD,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06717347
Phase3, Recruiting
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Location: Orange City FL, Plantation FL, Wilson NC, Greenville NC,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06758401
Phase3, Recruiting
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
for
Extensive-Stage Small Cell Lung Cancer
Location: Orange City FL, St. Petersburg FL, Fort Myers FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06646276
Phase3, Recruiting
TR(ACE) Assay Clinical Specimen Study
for
Carcinoma, Non-Small-Cell Lung, Breast Neoplasms
Location: Orange City FL, Winter Haven FL, Greenville SC,
Sponsor: Biological Dynamics
Sex: All
Age: 21+
Code: NCT02934360
Recruiting
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
for
Attention-Deficit/Hyperactivity Disorder
Location: Orange City FL, Winter Park FL, Orlando FL,
Sponsor: Supernus Pharmaceuticals, Inc.
Sex: All
Age: 4 - 5
Code: NCT04781140
Recruiting
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Episode (MDE), Major Depressive Disorder (MDD),
Location: Orange City FL, Maitland FL, Orlando FL,
Sponsor: Tonix Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07621237
Phase2, Recruiting
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
for
Ulcerative Colitis, Crohn's Disease
Location: Orange City FL, Orlando FL, Kissimmee FL,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT06581328
Recruiting
Prospective Study to Assess a Diagnostic Aid for Cancer
for
Cancer
Location: Orange City FL, Tampa FL, Stuart FL, Jupiter FL,
Sponsor: Harbinger Health
Sex: All
Age: 45+
Code: NCT07046260
Recruiting
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
for
Arthritis, Psoriatic
Location: DeBary FL, New Port Richey FL, Tampa FL, Clearwater FL,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06807424
Phase3, Recruiting
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
Location: DeBary FL, Tampa FL, Pembroke Pines FL, Hollywood FL,
Sponsor: EMD Serono Research & Development Institute, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07355218
Phase3, Recruiting
A Study of Dotinurad Versus Allopurinol in Participants With Gout
for
Gout
Location: Orlando FL, Winter Park FL, Lakeland FL, Tampa FL,
Sponsor: Crystalys Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07089875
Phase3, Recruiting
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
for
Tophaceous Gout
Location: Orlando FL, Winter Park FL, Lakeland FL, Tampa FL,
Sponsor: Crystalys Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07089888
Phase3, Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: DeBary FL, Orlando FL, Tampa FL, Clearwater FL,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06883305
Phase3, Recruiting
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
for
Cutaneous Lupus Erythematosus (CLE),
Location: DeBary FL, Tampa FL, Clearwater FL, Memphis TN,